Response Genetics Inc. (RGDXQ)

[mick]

RGDXQ Response Genetics, Inc.

https://www.otcmarkets.com/stock/RGDXQ/profile

Response develops, manufactures and markets rapid onsite
diagnostic tests for use with its RAMP platform for clinical,
biodefense and environmental applications.

RAMP represents a unique paradigm in diagnostics that provides reliable, quality results in minutes.

The RAMP platform consists of a reader and single use disposable
test cartridges and has the potential to be adapted to any other
medical and nonmedical immunoassay based test currently performed
in laboratories. Response clinical tests are commercially available
for the aid in early detection of heart attack, congestive heart failure, thromboembolism and infectious diseases.

In the nonclinical market,
RAMP tests are currently available for the environmental detection
of West Nile Virus antigen and for Biodefense applications including
the rapid onsite detection of anthrax,
smallpox,
ricin and
toxin.